Connection

Michal Pedziwiatr to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications Michal Pedziwiatr has written about Receptor, ErbB-2.
Michal Pedziwiatr
Connection Strength
0.033
Receptor, ErbB-2
  1. Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial. Med Oncol. 2015 Oct; 32(10):242.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.